Latest News

uniQure Expanding Clinical Pipeline to Fabry Disease
uniQure Expanding Clinical Pipeline to Fabry Disease

November 30th 2023

The IND clearance sets AMT-191 to be evaluated in a clinical trial alongside the company's gene therapies for ALS and Huntington disease.

Marcela Maus, MD, PhD, on New Approaches to CAR T-Cell Therapy for Solid Tumors
Marcela Maus, MD, PhD, on New Approaches to CAR T-Cell Therapy for Solid Tumors

November 30th 2023

Tiffany Chen, PhD, on the Role of Preclinical Models in Cell Therapy Research for Autoimmune Disease
Tiffany Chen, PhD, on the Role of Preclinical Models in Cell Therapy Research for Autoimmune Disease

November 30th 2023

Around the Helix: Cell and Gene Therapy Company Updates – November 29, 2023
Around the Helix: Cell and Gene Therapy Company Updates – November 29, 2023

November 29th 2023

Autolus Submits Obe-Cel BLA for Adult B-ALL
Autolus Submits Obe-Cel BLA for Adult R/R B-ALL

November 29th 2023

Video Interviews

Conference Coverage

View All
Tiffany Chen, PhD, on the Role of Preclinical Models in Cell Therapy Research for Autoimmune Disease
Tiffany Chen, PhD, on the Role of Preclinical Models in Cell Therapy Research for Autoimmune Disease

November 30th 2023

Eileen Tzng, BA, on Exploring Exosome and RNA-based Treatment Methods for Hearth Failure
Eileen Tzng, BA, on Exploring Exosome and RNA-based Treatment Methods for Hearth Failure

November 29th 2023

Novel Vector Development is Essential as Gene Therapy Emerges as a New Therapeutic Modality in Cardiology
Novel Vector Development is Essential as Gene Therapy Emerges as a New Therapeutic Modality in Cardiology

November 26th 2023

Fernanda Mesquita, PhD, on Using LAMA2-Exosomes to Improve Cardiomyocyte Survival in Stroke
Fernanda Mesquita, PhD, on Using LAMA2-Exosomes to Improve Cardiomyocyte Survival in Stroke

November 26th 2023

All News

© 2023 MJH Life Sciences

All rights reserved.